A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/24/2002	CA2430322A1 Use of clya hemolysin for excretion of proteins
10/23/2002	WO2001081331A1 Hydrates and crystals of a neuraminic acid compound
10/23/2002	EP1251134A1 Novel carbapenem derivatives of quaternary salt type
10/23/2002	EP1251133A1 Novel carbapenem derivatives
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250933A1 Vaccines including as an adjuvant high dose type I IFN
10/23/2002	EP1250932A1 A stable aqua formulation of interferon, the preparation method and the uses thereof
10/23/2002	EP1250917A2 Compositions for the control of microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio
10/23/2002	EP1250849A1 Morinda citrifolia (Noni) enhanced animal food product
10/23/2002	EP1250842A1 Composition for controlling microorganisms containing an effective amount of polyglycerinesters
10/23/2002	EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002	EP1250422A2 Myeloid colony stimulating factor and uses thereof
10/23/2002	EP1250355A1 Chimeric prostate-homing peptides with pro-apoptotic activity
10/23/2002	EP1250343A1 Azalide antibiotic compositions
10/23/2002	EP1250154A2 G-csf conjugates
10/23/2002	EP1250151A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250130A1 Propofol formulation with enhanced microbial inhibition
10/23/2002	EP1250125A2 Pharmaceutical compositions comprising terbinafine
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250056A1 Composition for intestinal delivery
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1179012B1 Long lasting fusion peptide inhibitors of viral infection
10/23/2002	EP1178903B1 Drive system
10/23/2002	EP1161427B1 Improved process for asymmetric hydrogenation
10/23/2002	EP1150702B1 Use of orosomucoid for the production of a pharmaceutical preparation for the treatment of pancreatitis
10/23/2002	EP0979229B1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
10/23/2002	EP0918533B1 Anti-chlamydial methods and materials
10/23/2002	EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002	EP0826000B1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
10/23/2002	EP0723552B1 Oligopeptides derived from c-reactive protein fragments
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376200A DNA vaccine-PCV
10/23/2002	CN1376161A Novel bicyclonucleoside analogues
10/23/2002	CN1376160A Novel macrolide antibiotics
10/23/2002	CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002	CN1376148A Rate-controlled particles
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1376073A Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation
10/23/2002	CN1376065A Compositions having improved stability
10/23/2002	CN1376063A Cyclic amine CCR3 antagonisis
10/23/2002	CN1376057A Anti-virus composition
10/23/2002	CN1376056A Liposome-entrapped DNA oral vaccines
10/23/2002	CN1376055A Aerosol ointment compositions and method of manufacture
10/23/2002	CN1376036A Metal-containing compositions, preparations and uses
10/23/2002	CN1375502A Polyglycol modified recombinant human interferon
10/23/2002	CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/23/2002	CN1375325A Composite medicine for treating hepatitis B
10/23/2002	CN1375314A Fermented soybean extracted liquid and composite medicine containing the said liquid
10/23/2002	CN1375300A Chinese medicine for preventing and treating cold
10/23/2002	CN1375298A Pain-relieving notoginseng mixture
10/23/2002	CN1375289A Ampelosis general flavone composition with liver protecting function
10/23/2002	CN1375247A Healthy shoes of konjaku
10/23/2002	CN1093172C Hepatitis C virus and its external cell culture method
10/23/2002	CN1092976C Application of endive in preparing medicine for treating tuberculosis
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469160 Crystalline forms of an antiviral benzimidazole compound
10/22/2002	US6469137 Myelopeptides and their therapeutic use
10/22/2002	US6469067 For treatment of livestock for parasites; comprises 1-(4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy) phenyl)-3-(2,6-difluorobenzoyl)urea and one of: ivermectin, doramectin, moxidectin and selamectin
10/22/2002	US6469054 Aryl sulphonamides and analogues
10/22/2002	US6469046 Fabh inhibitors which are useful as antibiotics for the treatment of gram positive and gram negative bacterial infections
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469034 Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002	US6469018 Compounds
10/22/2002	US6469016 Treatment of female sexual dysfunction using phosphodiesterase inhibitors
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	US6468992 Phosphonic acid diester derivatives
10/22/2002	US6468991 Method of treating rhinoviral infections
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002	US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/22/2002	US6468967 Methods for administration of antibiotics
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468545 Helicobacter pylori catalase.
10/22/2002	US6468544 Genetically engineered influenza a virus with an interferon-inducing phenotype wherein said virus comprises a viral genome wherein the complete ns1 coding sequences have been deleted (delns1).
10/22/2002	US6468542 Germination activated Ganoderma lucidum spores and method for producing the same
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	US6468534 Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/22/2002	US6468519 Polyanhydrides with biologically active degradation products
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/22/2002	CA2095335C Cell growth inhibitors
10/22/2002	CA2084093C Composite molecular system for the contra-escalatory treatment of viral infections
10/22/2002	CA2040544C Actinobacillus pleuropneumoniae subunit vaccine
10/20/2002	CA2380211A1 Compositions for controlling microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio
10/20/2002	CA2380210A1 Compositions for controlling microorganisms, comprising an effective content of enzymatically prepared esters of polyglycerol
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria

1 ... 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 ... 1798